多巴酚丁胺联合参麦治疗肺心病急性心衰的临床研究

Observation on Effect of Dobutamine and Shenmai in Treating Pulmonary Heart Disease with Acute Congestive Heart Failure

目的:探讨多巴酚丁胺联合参麦治疗肺心病急性心衰的疗效。方法:将我院肺心病急性心衰患者80例随机分为观察组和对照组,对照组给予常规治疗,观察组给予多巴酚丁胺联合参麦治疗,评估两组临床治疗效果及安全性。结果:观察组患者总有效率明显高于对照组,两组比较差异具有统计学意义(P<0.05)。治疗后观察组全血黏度、红细胞压积、纤维蛋白原、血沉明显优于对照组,两组比较差异具有统计学意义(P<0.05)。结论:多巴酚丁胺联合参麦治疗肺心病急性心衰的疗效明确,值得应用。

Objective.To investigate the effect of dobutamine and shenmai in treating pulmonary heart disease with acute congestive heart failure. Methods. The 80 cases with pulmonary heart disease with acute congestive heart failure were divided into the observe group and the control group. The control group received the normal chemotherapy treatment, and at the same time the observe group received the treatment of dobutamine and shenmai. Results：The total rate in the observe group was more than those in control group （P〈0. 05）. The whole human blood whole human blood, hematocrit;packed red cell volume, fibrinogen and blood sedimentation in the observe group was superiot to that in control group （P〈0. 05）. Conclusion：The effect of dobutamine and shenmai in treating pulmonary heart disease with acute congestive heart failure is obvious and the subsidiary reaction is few, so they are worth being used.